Study of the change of dietary intake and contents after taking selective SGLT2 inhibitor, Ipragliflozin

Trial Profile

Study of the change of dietary intake and contents after taking selective SGLT2 inhibitor, Ipragliflozin

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 20 Dec 2014

At a glance

  • Drugs Ipragliflozin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Dec 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top